Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) saw a large growth in short interest in July. As of July 15th, there was short interest totalling 11,500 shares, a growth of 26.4% from the June 30th total of 9,100 shares. Based on an average daily trading volume, of 181,200 shares, the short-interest ratio is currently 0.1 days.

Bioxytran Price Performance

BIXT traded down $0.01 on Monday, reaching $0.12. The stock had a trading volume of 6,400 shares, compared to its average volume of 94,972. The firm has a 50-day moving average of $0.11 and a 200-day moving average of $0.12. Bioxytran has a fifty-two week low of $0.07 and a fifty-two week high of $0.35.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.